We wish to inform you about the financial assistance of the participating companies according to their membership in FSA e.V. (Association for Voluntary Self-Control of the Pharmaceutical Industry), AKG e.V. (Association for Medicinal Products and Cooperation in the Health Sector) or because the companies have approved the publication.
Regardless of the above-mentioned memberships, the conditions and scope of financial assistance of all companies as well as specialist publishers who support the event will be published, if this is stipulated by the professional codes of the respective regional medical associations.
Moreover, this complies with the recommendations of the Federal Medical Association (Bundesärztekammer) on continuing medical education, 4th revised edition, last updated: 24 April 2015, p.11 et seq., section 32 para. (3) of the (Model) Professional Code for Physicians in Germany ((Muster-)Berufsordnung für die in Deutschland tätigen Ärztinnen und Ärzte – MBO), section 8 para. (1) no. 3 of the (Model) Continuing Medical Education Code (Musterfortbildungsordnung – MFO).

The content of this event is designed to be product- and service-neutral. We confirm that the scientific management and the speakers will disclose potential conflicts of interest to the participants. The following companies are sponsors:

Angiodroid SpA. 12.000,00 EUR, BD Becton Dickinson GmbH 10.000,00 EUR, Bentley InnoMed GmbH 17.000,00 EUR, BIOTRONIK Vertriebs GmbH & Co. KG 7.000,00 EUR, Lamed GmbH 17.000,00 EUR, NXT MED GmbH 5.000,00 EUR, Optimed Medizinische Instrumente GmbH 17.000,00 EUR, Penumbra Europe GmbH 10.000,00 EUR, Scanlan International, Inc. 5.000,00 EUR, L. Gore & Associates GmbH 8.700,00 EUR.

The total costs of the event amount to approx. 200.000€.

 Jan 2025